Skip to content

Effects of rTMS over the Contralateral M1 Area Combined with NMES on Nocturnal Pain and Functional Mobility in Primary Frozen Shoulder

Effects of rTMS over the Contralateral M1 Area Combined with NMES on Nocturnal Pain and Functional Mobility in Primary Frozen Shoulder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098406
Enrollment
Unknown
Registered
2025-03-07
Start date
2025-03-16
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen Shoulder

Interventions

Experimental group A:Low frequency-rTMS
Experimental group B:High frequency-rTMS

Sponsors

Shanghai Seventh People‘s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with >=18 years of age with unilateral shoulder pain; (2) 25% reduction in range of motion in at least two planes of motion compared to the unaffected shoulder; (3) Pain duration =3; (4) Shoulder X-ray examination was normal; (5) Those who voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with secondary frozen shoulder and other shoulder diseases (such as shoulder deformity, fracture, dislocation, arthritis, cervical radiculopathy, history of previous shoulder surgery, rotator cuff injury or subacromial impingement syndrome, calcific tendonitis and osteoarthritis, etc.); (2) Shoulder pain secondary to other diseases (such as fibromyalgia, rheumatic diseases, trauma, etc.); (3) Patients who have received intra-articular corticosteroid injections in the affected shoulder within the past 3 months; (4) Patients with a diagnosis of frozen shoulder in both shoulders; (5) Suffering from other comorbidities (such as cardiovascular diseases, nervous system diseases, liver and kidney dysfunction, malignant tumors, high fever, infectious diseases and cognitive diseases, etc.); (6) Patients who are unable to complete MRI scans; (7) Patients with cognitive dysfunction, psychiatric disorders, or inability to understand and cooperate with the investigator or provide informed consent; (8) Other circumstances that the investigator deems inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Constant-Murley Score;

Secondary

MeasureTime frame
Polysomnography;Surface electromyography(sEMG);Motor evoked potential (MEP);Magnetic Resonance Imaging, MRI;36-Item Short Form Survey;

Countries

China

Contacts

Public ContactZhou Huanxia

Shanghai Seventh People‘s Hospital

zhouhuanxia7@163.com+86 136 4164 9864

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026